Imran Shahid

Umm al-Qura University Saudi Arabia

Dr. Imran Shahid is an assistant Professor at Umm Al-Qura University, Makkah, Saudi Arabia where his research is focused on the broad areas of host-virus networks in HCV disease progression as well as host-virus genes expression during oxidative stress, hepatic steatosis, fibrosis, and hepatocellular carcinoma. He is also enthusiastically involved in the studies of tyrosine kinase inhibitors for the treatment of breast and colon cancer, in the Saudi population. He was trained from applied and functional genomics laboratory, National Centre of Excellence in Molecular Biology (NCEMB), University of Punjab; Lahore, Pakistan where he worked on anti-mRNA based treatment strategies against hepatitis C virus 1a genotype in Pakistani population. Dr. Imran has published many research articles in peer-reviewed international journals and is a member of the editorial board of several international journals.

1books edited

5chapters authored

Latest work with IntechOpen by Imran Shahid

The propagation of hepatitis C from acute to chronic infection and afterward to end-stage liver diseases (hepatic fibrosis, cirrhosis, and hepatocellular carcinoma) involves a highly orchestrated series of molecular and cellular events, including a plethora of genes and cell signaling cascades. The treatment paradigms was revolutionized after the development and approval of all oral interferon-free direct-acting antivirals achieving higher sustained virologic response rates in treated individuals. This book pragmatically overviews the intricate interplay between viral and host factors during hepatitis C virus infection progression, as well as other hepatitis C-associated clinical implications. Hepatitis C - From Infection to Cure also provides up-to-date information about hepatitis C cures for clinicians, physicians, and healthcare providers with an ample understanding of the current treatment horizon, as well as other investigational and emerging treatment strategies. The authors with their valuable scientific contributions belong to many eminent institutes around the world and are much experienced in hepatitis C virology, pathology, and therapeutics.

Go to the book